26 May 2013
Keywords: mmd, develop, gensia, compound, marion, merrell, dow
Article | 07 September 1992
Marion Merrell Dow has announced that it will license and continue the
development of GP-1-468-3, an analog of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 September 1992
3 August 1992
24 May 2013
© 2013 thepharmaletter.com